JP2022541341A5 - - Google Patents

Info

Publication number
JP2022541341A5
JP2022541341A5 JP2022505341A JP2022505341A JP2022541341A5 JP 2022541341 A5 JP2022541341 A5 JP 2022541341A5 JP 2022505341 A JP2022505341 A JP 2022505341A JP 2022505341 A JP2022505341 A JP 2022505341A JP 2022541341 A5 JP2022541341 A5 JP 2022541341A5
Authority
JP
Japan
Prior art keywords
article
therapeutic agent
article according
disease
steroid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022505341A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022541341A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2020/000620 external-priority patent/WO2021014217A1/en
Publication of JP2022541341A publication Critical patent/JP2022541341A/ja
Publication of JP2022541341A5 publication Critical patent/JP2022541341A5/ja
Pending legal-status Critical Current

Links

JP2022505341A 2019-07-25 2020-07-24 ステロイド二量体を含む物品と治療剤の送達におけるそれらの使用 Pending JP2022541341A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962878477P 2019-07-25 2019-07-25
US62/878,477 2019-07-25
PCT/IB2020/000620 WO2021014217A1 (en) 2019-07-25 2020-07-24 Articles comprising steroid dimers and their use in the delivery of therapeutic agents

Publications (2)

Publication Number Publication Date
JP2022541341A JP2022541341A (ja) 2022-09-22
JP2022541341A5 true JP2022541341A5 (cg-RX-API-DMAC7.html) 2023-08-01

Family

ID=74192465

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022505341A Pending JP2022541341A (ja) 2019-07-25 2020-07-24 ステロイド二量体を含む物品と治療剤の送達におけるそれらの使用

Country Status (5)

Country Link
US (1) US20220289787A1 (cg-RX-API-DMAC7.html)
EP (1) EP4003362A4 (cg-RX-API-DMAC7.html)
JP (1) JP2022541341A (cg-RX-API-DMAC7.html)
CN (1) CN114728011A (cg-RX-API-DMAC7.html)
WO (1) WO2021014217A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3740494A4 (en) 2018-02-02 2021-11-03 Ripple Therapeutics Corporation GLASS FORMULATIONS WITH STEROID DIMERS AND USES THEREOF
WO2020154815A1 (en) 2019-02-01 2020-08-06 Ripple Therapeutics Corporation Crystalline forms of dexamethasone dimers and uses thereof
US12509469B2 (en) 2019-08-07 2025-12-30 Ripple Therapeutics Corporation Compositions and methods for the treatment of pain and dependence disorders
CA3176134A1 (en) 2020-05-01 2021-11-04 Ripple Therapeutics Corporation Heterodimer compositions and methods for the treatment of ocular disorders
US20260007686A1 (en) * 2022-07-12 2026-01-08 Ripple Therapeutics Corporation Compositions and methods for improving vision
WO2025049690A1 (en) * 2023-08-29 2025-03-06 Orna Therapeutics, Inc. Circular polyethylene glycol lipids

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68915784T2 (de) * 1989-03-09 1994-09-29 Endocom, Inc., Boston, Mass. Teilweise geschmolzenes peptidpellet.
BR8907883A (pt) * 1989-03-09 1991-12-24 Endocon Inc Pelota de peptideo parcialmente fundida e seu processo de fabricacao
PT740650E (pt) * 1994-01-28 2004-10-29 Univ Kentucky Res Found Co-farmacos como um metodo de administracao controlada de farmacos
US9056048B2 (en) * 2001-08-16 2015-06-16 The Trustees Of The University Of Pennsylvania Synthesis and use of cationic steroids for anti-inflammatory drug therapy
US20030158598A1 (en) * 2001-09-17 2003-08-21 Control Delivery Systems, Inc. System for sustained-release delivery of anti-inflammatory agents from a coated medical device
EP2968698B1 (en) * 2013-03-15 2018-01-10 Interface Biologics Inc. Coating for drug release
WO2017083794A1 (en) * 2015-11-12 2017-05-18 Board Of Regents Of The University Of Nebraska Polyethylene glycol-conjugated glucocorticoid prodrugs and compositions and methods thereof
EP3740494A4 (en) * 2018-02-02 2021-11-03 Ripple Therapeutics Corporation GLASS FORMULATIONS WITH STEROID DIMERS AND USES THEREOF

Similar Documents

Publication Publication Date Title
KR100483870B1 (ko) 양성자펌프억제제및비스테로이드성항염증약물을포함하는경구제약제형
JP2022545835A5 (cg-RX-API-DMAC7.html)
JP2025020134A5 (cg-RX-API-DMAC7.html)
ES2977953T3 (es) Comprimido
JP2024075655A5 (ja) 鏡像異性体的に純粋なブプロピオンの医薬の製造における使用
DE13156663T1 (de) NRF2-Screening-Assays sowie entsprechende Verfahren und Zusammensetzungen
JP2025020117A5 (cg-RX-API-DMAC7.html)
JP2024523003A5 (cg-RX-API-DMAC7.html)
SK6412002A3 (en) Pharmaceutical formulation containing tolterodine and its use
JP2010500371A5 (cg-RX-API-DMAC7.html)
JP2019203035A5 (cg-RX-API-DMAC7.html)
JP2020521797A5 (cg-RX-API-DMAC7.html)
JP2024516363A5 (cg-RX-API-DMAC7.html)
JP2006513184A5 (cg-RX-API-DMAC7.html)
JP2019501191A5 (cg-RX-API-DMAC7.html)
JP2022550434A5 (cg-RX-API-DMAC7.html)
JP2024520727A5 (cg-RX-API-DMAC7.html)
JP2024523559A5 (cg-RX-API-DMAC7.html)
JP2022548464A5 (cg-RX-API-DMAC7.html)
CN101939001B (zh) 用于治疗卵巢癌的含有紫杉醇的组合
JPS62111916A (ja) 一定の放出性を保持した薬物粒子
JP2021502347A5 (cg-RX-API-DMAC7.html)
JP2025148449A5 (cg-RX-API-DMAC7.html)
CN1630511A (zh) 表现出s形曲线模式控释的依来曲帕滕颗粒组合物
KR100581967B1 (ko) 소화성 궤양 치료를 위한 프로톤펌프 저해제와클래리스로마이신을 함유하는 이중 펠렛 제제 및 그의제조방법